Back to Screener

MiniMed Group, Inc. - Common Stock (MMED)

NASDAQ Mid Cap
$11.73
Market Cap: $3.3B
Data as of Jan 23, 2026 (TTM)

Price History

Mar 29, 2026 — May 8, 2026

Investment Snapshot

  • P/B of 0.95 — trading below book value
  • Piotroski F-Score 0/9 — signs of financial weakness
  • Loss-making — negative ROE of -4.3%

MiniMed Group, Inc. - Common Stock (MMED) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $3.3 billion . Key value metrics: P/B ratio 0.95, Piotroski F-Score 0 out of 9 .

Value Score

Key Metrics

P/E Ratio
0.95
EPS
$-0.53
Div. Yield
PEG Ratio
P/S Ratio
EV/EBITDA
ROE
ROA
Gross Margin
Op. Margin
Net Margin
Debt/Equity
Current Ratio
Data sourced from SEC EDGAR and Polygon.io. Methodology.

MiniMed Group, Inc. - Common Stock — Fundamental Analysis Summary

On financial health, MMED shows a weak Piotroski F-Score of 0/9, a signal of deteriorating financial health, and negative return on equity of -4.3%.

StockPik's composite Value Score for MMED is 48/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

Stocks below book value
Other stocks trading at a discount to net assets (P/B < 1)
How is the Value Score calculated?
Read our full methodology →
What is the Piotroski F-Score?
The 9-point financial health score explained, with worked examples →
Previous
MMA
Next
MMI